Company Profile
Weihua Pharma Co.,Ltd., established on 1998, located in Xisha Industrial Park of Hangzhou, Zhejiang province, near Zhejiang University , is a modern APIs and pharmaceutical intermediates enterprise, gathering R&D, production and sales in one body. The R&D center, equipped with advanced testing facilities and professional team. We can also provide Contract Manufacturing, Customer Research and manufacturing service. We mainy produce a series of VD products such as calcitriol, Calcipotriol, Alfacalcidol, Doxercalciferol, Tacalcitol, Doxercalciferol and Paricalcitol, Calcifediol, 25-OH Vitamin D2, 1 α 25-OH Vitamin D2, etc. Our exquisite technology, strict control over quality, advanced detective equipment as well as powerful technical personnal guarantee the high quality of our products. Weihua Pharma Co., Ltd. enjoys a good reputation among its customers all over the world for running efficiently upon low cost and being outstanding among its competitors. We also accept custom synthesize service. Welcome to cooperate with your esteemed company.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
99.0%MIN. Purity Hot Sale Sex Enhancement Acetildenafil Hongdenafil Powder |
7H-Pyrazolo[4,3-d]pyrimidin-7-one,5-[2-ethoxy-5-[2-(4-ethyl-1-piperazinyl)acetyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-;7H-Pyrazolo[4,3-d]pyrimidin-7-one,5-[2-ethoxy-5-[(4-ethyl-1-piperazinyl)acetyl]phenyl]-1,4-dihydro-1-methyl-3-propyl-;5-[2-Ethoxy-5-[2-(4-ethyl-1-piperazinyl)acetyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one;Acetildenafil;Hongdenafil;874184-87-9 |
831217-01-7 | Inquiry | |
99.0%MIN. Purity Hot Sale Sex Enhancement Avanafil Powder |
5-Pyrimidinecarboxamide,4-[[(3-chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-;4-[[(3-Chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide;(S)-2-(2-Hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylamino)-5-[N-(2-pyrimidinylmethyl)carbamoyl]pyrimidine;TA 1790;Avanafil;(S)-4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide;Spedra;330785-17-6;647841-09-6 |
330784-47-9 | Inquiry | |
99.0%MIN. Purity Hot Sale Sex Enhancement Dapoxetine Hcl Priligy Raw Powder |
DL-Dapoxteine HCL;N,N-DiMethyl-1-phenyl-3-(1-naphthalenyloxy)propanaMinehydrochloride;(S)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine hydrochloride;Dapoxetine/Dapoxetine HCl/Dapoxetine hydrochloride;LY-210448 hydrochloride;Priligy;PRILIGY;LY-210448 HYDROCHLORIDE;(S)-N,N-dimethyl-3- |
129938-20-1 | Inquiry | |
99.0%MIN. Purity Hot Sale Sex Enhancement Mirodenafil Powder |
5-Ethyl-3,5-dihydro-2-[5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]-2-propoxyphenyl]-7-propyl-4H-pyrrolo[3,2-d]pyrimidin-4-one;MIRODENAFIL;5-ethyl-2-[5-[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl-2-propoxyphenyl]-7-propyl-1H-pyrrolo[3,2-d]pyrimidin-4-one;4H-Pyrrolo[3,2-d]pyriMidin-4-one,5-ethyl-3,5-dihydro-2-[5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]-2-propoxyphenyl]-7-propyl-;Mirodenafil, >=98%;5-Ethyl-2-(5-{[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl}-2-propoxyphenyl)-7-propyl-1,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one;MILONAFIL;Mirodenafil Solution, 100μg/mL |
862189-95-5 | Inquiry | |
99.0%MIN. Purity Hot Sale Sex Enhancement Phentolamine Mesylate vasomax Powder |
Phenol,3-[[(4,5-dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)amino]-,methanesulfonate (1:1);Phenol,m-[N-(2-imidazolin-2-ylmethyl)-p-toluidino]-,monomethanesulfonate (salt);Phenol,3-[[(4,5-dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)amino]-,monomethanesulfonate (salt);m-[N-(2-Imidazolin-2-ylmethyl)-p-toluidino]phenol methanesulfonate;Phentolamine mesylate;Phentolamine methanesulfonate;Regitine methanesulfonate;Regitin methanesulphonate;Phentolamine methanesulphonate;Regitine mesylate;Vasomax;Rogitine;252228-09-4 |
65-28-1 | Inquiry | |
Alfacalcidol |
1,3-Cyclohexanediol,5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-1,5-dimethylhexyl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-,(1R,3R)-;9,10-Secocholesta-5,7,10(19)-triene-1,3-diol,(1α,3β,5Z,7E)-;(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-1,5-Dimethylhexyl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-1,3-cyclohexanediol;1α-Hydroxycholecalciferol;1α-Hydroxyvitamin D3;1-Hydroxycholecalciferol;1-Hydroxyvitamin D3;Alfacalcidol;Un Alpha;α-Calcidol;Alfarol;Alphacalcidol;Oxydevit;Alpharol;Bondiol;Un Alfa;Etalpha;1α(OH)D3;Alpha D3;EinsAlpha;(1S)-Hydroxycalciol;Tevabone;125324-15-4;41461-06-7;43157-29-5;43217-90-9 |
41294-56-8 | Inquiry | |
Alisertib |
Benzoic acid,4-[[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxy-;4-[[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid;MLN 8237;Alisertib;1186318-95-5 |
1028486-01-2 | Inquiry | |
Amuvatinib |
N-(1,3-Benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide;1-Piperazinecarbothioamide, N-(1,3-benzodioxol-5-ylmethyl)-4-benzofuro(3,2-D)pyrimidin-4-yl-;Mp470;AMuvatinib;HPK 56;MP-470(MP 470);AMuvatinib (MP-470);AMuvatinib (MP-470, HPK 56) |
850879-09-3 | Inquiry | |
Anguizole |
Anguizole;7-[chloro(difluoro)methyl]-5-(furan-2-yl)-N-(thiophen-2-ylmethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide;C17H11ClF2N4O2S;CHEMBL2170006;SCHEMBL14366829;DTXSID30359937;ZINC720413;BCP21132;3447AH;AKOS025149511 |
442666-98-0 | Inquiry | |
Calcifediol |
Calcifediol /25-Dihydroxyvitamin D3;25-OH-VD3;Calcifediol/25-Hydroxycholecalciferol H20;CALCIDIOL;CALCIFEDIOL;CALCIFEDIOL MONOHYDRATE;25-OH-D3;25-HYDROXYVITAMIN D3 |
63283-36-3 | Inquiry | |
Calcipotriol |
Calcipotrien;(1R,3S,5Z)-5-[(2E)-2-[(1R,7aR)-1-[(E,2R,5S)-5-cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylenecyclohexane-1,3-diol;(1R,3S,5Z)-5-{2-[(4E)-1-[(2R,3E,5R)-5-CYCLOPROPYL-5-HYDROXYPENT-3-EN-2-YL]-7A-METHYL-HEXAHYDRO-1H-IN;Calcipotriene/calcipotriol;CALCIPOTRIOL;(1s,3s,5z)-5-[(2e)-2-[(1r,3ar,7ar)-1-[(e,2s)-5-cyclopropyl-5-hydroxy-pent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol;(1r,3s,5z)-5-[(2e)-2-[1-[(e,2r,5r)-5-cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;24-CYCLOPROPYL-(1ALPHA,3BETA,5Z,7E,22E,24S)-9,10-SECOCHOLA-5,7,10(19),22-TETRAENE-1,3,24-TRIOL |
112828-00-9 | Inquiry | |
Doxercalciferol |
1,3-Cyclohexanediol,4-methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-7a-methyl-1-[(1R,2E,4R)-1,4,5-trimethyl-2-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-,(1R,3S,5Z)-;9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol,(1α,3β,5Z,7E,22E,24R)-;(1R,3S,5Z)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-7a-methyl-1-[(1R,2E,4R)-1,4,5-trimethyl-2-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol;1α-Hydroxyvitamin D2;1α-Hydroxyergocalciferol;1-Hydroxyergocalciferol;1-Hydroxyvitamin D2;TSA 840;Doxercalciferol;Hectorol;125285-48-5;87649-67-0 |
54573-75-0 | Inquiry | |
Durvalumab(AZD9291) |
2-Propenamide,N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-;N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide;AZD 9291;Osimertinib;Tagrisso;1610419-47-0 |
1421373-65-0 | Inquiry | |
Elacridar |
4-Acridinecarboxamide,N-[4-[2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-;N-[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamide;GF 120918;GG 918;Elacridar;GW 0918;GF 129018 |
143664-11-3 | Inquiry | |
Ispinesib |
Ispinesib;N-(3-Aminopropyl)-N-[(1R)-1-[7-chloro-3,4-dihydro-4-oxo-3-(phenylmethyl)-2-quinazolinyl]-2-methylpropyl]-4-methylbenzamide;SB 715992;Benzamide, N-(3-aminopropyl)-N-((1R)-1-(7-chloro-3,4-dihydro-4-oxo-3-(phenylmethyl)-2-quinazolinyl)-2-methylpropyl)-4-methyl-;Unii-bkt5F9C2ni;Ispinesib2;SB-71599;Ispinesib (SB-715992 /CK0238273) |
336113-53-2 | Inquiry | |
Ivacaftor |
3-Quinolinecarboxamide,N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-;N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide;VX 770;Ivacaftor;Kalydeco;N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide;N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide;N-[2,4-Di(tert-butyl)-5-hydroxyphenyl]-4-oxo-1H,4H-quinoline-3-carboxamide;1174930-71-2 |
873054-44-5 | Inquiry | |
Lestaurtinib |
9,12-Epoxy-1H-diindolo[1,2,3-fg:3′,2′,1′-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one,2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-,(9S,10S,12R)-;9,12-Epoxy-1H-diindolo[1,2,3-fg:3′,2′,1′-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one,2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-,[9S-(9α,10β,12α)]-;(9S,10S,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3′,2′,1′-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one;KT 5555;CEP 701;SP 924;A 154475.0;Lestaurtinib;NSC 621867;156256-78-9 |
111358-88-4 | Inquiry | |
Maxacalcitol |
MAXACALCITOL;(1R,3S,5Z)-5-[(2E)-2-[(1S,3aS,7aS)-1-[(1S)-1-(3-hydroxy-3-methylbutoxy)ethyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;(5Z,7E)-9,10-Seco-22-oxacholesta-5,7,10(19)-triene-1α,3β,25-triol;22-Oxa-1α,25-dihydroxycholecalciferol;Oxacalcitriol;(+)-(5Z,7E)-(1S,3R,20S)-20-(3-Hydroxy-3-methylbutyloxy)-9,10-secopregna-5,7,10(19)-triene-1,3-diol;1,3-Cyclohexanediol, 4-methylene-5-[(2E)-2-[(1S,3aS,7aS)-octahydro-1-[(1S)-1-(3-hydroxy-3-methylbutoxy)ethyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1R,3S,5Z)-;(1R,3S,5Z)-4-Methylene-5-[(2E)-2-[(1S,3aS,7aS)-octahydro-1-[(1S)-1-(3-hydroxy-3-methylbutoxy)ethyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol |
103909-75-7 | Inquiry | |
Paricalcitol |
1,3-Cyclohexanediol,5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-,(1R,3R,5Z)-;19-Nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol,(1α,3β,7E,22E)-;(1R,3R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-Octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol;Paricalcitol;Zemplar;19-Nor-1,25-dihydroxyvitamin D2;1α,25-Dihydroxy-19-nor-vitamin D2;19-Nor-1α-25-dihydroxyvitamin D2;539856-25-2 |
131918-61-1 | Inquiry | |
Pembrolizumab;Lambrolizumab(MK-3475) |
Pembrolizumab;Pembrolizumab (anti-PD-1);PEMBROLIMUMAB PD-1 1374853-91-4;Pembrolizumab 25mg/ml;PembrolizumabQ: What is
Pembrolizumab Q: What is the CAS Number of
Pembrolizumab Q: What is the storage condition of
Pembrolizumab Q: What are the applications of
Pembrolizumab;Research Grade Pembrolizumab(DHH02202);MK-3475;Research Grade Pembrolizumab |
1374853-91-4 | Inquiry |
CONTACT INFORMATION
Sign In for Details